Last 693.90
Change Today 0.00 / 0.00%
Volume 0.0
KNWT On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 10:24 AM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

16 Hatidhar Street

PO Box 4131

Raanana, 43665

Israel

Phone: 972 9 744 2440

Fax:

TopSpin Medical, Inc., through its subsidiary, Metamorefix Ltd. (Metamorefix), engages in the examination, research, and development of technologies that facilitate the healing, rejuvenation, and repair of tissues, such as skin tissues that have sustained damage from injuries, wounds, or due to aging. The technologies developed by Metamorefix are based on an integration of developed products into the body’s natural and spontaneous healing processes. The first technology developed by Metamorefix is based on a combination of hyaluronic acid and fibrin. Hyaluronic acid is a polymer that is found in various human tissues (such as skin and cartilage). It is known as a substance that promotes healing processes. Fibrin is a protein that is created naturally in the body after sustaining skin tissue damage (also known as ‘blood clotting’), Metamorefix developed controlled processes that allow for the formation of fibrin based on a combination of thrombin and fibrinogen, as a stable, functional powder, which serves as an optimal environment for cell growth. Metamorefix has chosen two fields for the implementation of the technology, such as aesthetics (the filling and treatment of wrinkles) and the healing of wounds. The product developed by Metamorefix is a natural tissue healing and dermal filler substance, which the company refers to as the Dermal Filler. The Dermal Filler contains hyaluronic acid combined with the fibrin powder. Suppliers The company’s suppliers include BioTechnology General (BTG) Israel, a company owned by Ferring Pharmaceuticals and Novozymes A/S. Regulations Metamorefix’s activities are subject to compliance with various local and international standards and the regulation of various authorities, including the United States Food & Drugs Administration; and the Israeli Ministry of Health. Research and Development As of December 31, 2011, the company invested a total of New Israeli Shekel 7,890,000 (approximately $2,064,904) in gross research and development expenses. Intellectual Property As of December 31, 2011, the company’s subsidiary, TopSpin Medical (Israel) Ltd., owned one registered patents in the United States. Competition The company’s major competitors include Kinetic Concepts (KCI); Smith & Nephew; ConvaTec; Molnlycke Health Care; Systagenix Wound Management; and Coloplast. History TopSpin Medical, Inc. was founded in 2007.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KNWT:IT 693.90 0.00

KNWT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KNWT.
View Industry Companies
 

Industry Analysis

KNWT

Industry Average

Valuation KNWT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MY SIZE INC, please visit www.topspin-medical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.